(Q44469161)
Statements
1 reference
A 48-week, randomized, open-label comparison of three abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy (English)
1 reference
G J Moyle
1 reference
C Baldwin
1 reference
B Langroudi
1 reference
S Mandalia
1 reference
B G Gazzard
1 reference
1 May 2003
1 reference
1 reference
33
1 reference
1
1 reference
22-28
1 reference
Identifiers
1 reference
1 reference